Mini Case Study
Mini Case Study
Mini Case Study
5 days prior to admission, patient experienced episodes of fever and anuria. For those 5
days, the first three days was where the patient experienced episodes of fever and for the next 2
days, anuria was manifested by the patient.
HEALTH ASSESSMENT
NEUROLOGICAL:
Sensorium: drowsy/lethargic
Speech: Slurred
Motor: paraplegia
Can follow simple commands
PUPILS:
1900H Right: Size (2 mm) Reaction (+)
Left: Size (2mm) Reaction (+)
2000H Right: Size (2 mm) Reaction (+)
Left: Size (2mm) Reaction (+)
MOTOR ACTIVITY:
1900H Arms: flexion
Legs: Weakness
2000H Arms: flexion
Legs: Weakness
RESPIRATORY:
Oxygenation: with oxygen inhalation at 1 lpm via nasal cannula
Breathing: with spontaneous and non-labored
Breath sounds: fine rales
CARDIOVASCULAR:
No chestpain
Swelling/ edema on extremities: upper extremities
Peripheral pulses: palpable, on all sites
Cardiac rhythm: sinus bradycardia
GASTRO-INTESTINAL:
No vomiting and nausea
Abdomen: round
Nutrition: NGT NPO except medication
Bowel Movement the whole shift: 0
Tube/drainage: NGT connected to the bedside
GENITO-URINARY
Bladder: non-distended
Tube/drainage: foley catheter (16)
Dark yellow urine
With episodes of anuria
INTEGUMENTARY:
Skin condition: warm
With rashes, bruises, laceration on the upper extremities (left arm)
With pressure ulcer at lower extremities (right leg)
Skin color: jaundiced
PSYCHOSOCIAL:
Mood Behavior: restless
Activities: CBR without bathroom privilege
May dangle legs
May sit up on bed
May use bedside commode
DRUG STUDY
Meropenem (Meromax)
Drug Classification:
Beta-lactam antibiotic
Drug Action/s: penetrates cell wall of most gram positive and gram negative bacteria to reach
penicillin-binding protein targets
Amiodarone (Anoion)
Drug Action/s: Prolongs action potential and refractory period. Inhibits adrenergic
stimulation. Slows the sinus rate, increases pulse rate and decreases peripheral vascular
resistance (vasodilation).
Contraindications:
1. Advise patient that photosensitivity reactions may occur. Protective clothing and sun-
block are recommended during and for 4 months after therapy.
2. Inform patients that blueish discoloration of the face, neck, and arms is a possible side
effects. This is usually reversible and will fade over several mo. Notify health care
professional if this occurs.
Generic and Brand Name of Drug:
Pantoprazole (Pantropaz)
Drug Action/s: Binds to an enzyme in the presence of gastric pH, preventing the final
transport of hydrogen ions into the gastric lumen.
40 mg IV Q12H
Contraindications:
Contraindicated in patients with a history of hypersensitivity to the drug itself, components of
the formulation, and/or other benzimidazole PPIs, including omeprazole, lansoprazole,
raberprazole, esomeprazole or dexlansoprazole.
1. Inform patient that pantoprazole may increase the risk of bone fractures.
2. Instruct patient to notify healthcare professional of all medications, vitamins, or herbal
products being taken and consult healthcare professional before taking any new
medications.
PATHOPHYSIOLOGY
Student Name: Dazlynne S. Cartujano CI: Mrs. Vanessa Langcay
RLE Group: 1
Community/Area: Manila Doctors Hospital (Intensive Care Unit)